← Open Payments lookup

MULIKAT OTEPOLA: Open Payments

NPI 1194219907 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$557 in 26 payments from 9 companies in 2025. Trend: 2023 $246 · 2024 $377 · 2025 $557

Food & beverage: $557
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$204
Janssen Pharmaceuticals, Inc8$149
Otsuka America Pharmaceutical, Inc.3$51
Neurocrine BioSciences, Inc.2$45
ABBVIE INC.2$33
Alkermes, Inc.2$27
Teva Pharmaceuticals USA, Inc.1$17
E.R. Squibb & Sons, L.L.C.1$16
Supernus Pharmaceuticals, Inc.1$14

Products named: CAPLYTA, INVEGA SUSTENNA, SPRAVATO, INGREZZA, VRAYLAR, REXULTI, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across NJ — which companies pay providers there.